tiprankstipranks
Protalix Biotherapeutics (DE:PBDA)
FRANKFURT:PBDA
Germany Market
PBDA
Protalix
RESEARCH TOOLSreports

Protalix (PBDA) Ratios

0 Followers

Protalix Ratios

DE:PBDA's free cash flow for Q2 2026 was $0.61. For the 2026 fiscal year, DE:PBDA's free cash flow was decreased by $ and operating cash flow was $0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.94 2.51 2.34 1.54 1.38
Quick Ratio
 1.91 1.54 1.52 1.12 0.87
Cash Ratio
 0.87 0.55 0.77 0.52 0.53
Solvency Ratio
 0.53 -0.15 0.14 0.19 -0.21
Operating Cash Flow Ratio
 0.32 -0.45 0.34 -0.03 -0.77
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 -0.06 0.00
Net Current Asset Value
$ 53.29M$ 32.56M$ 29.87M$ 19.07M$ -21.55M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.10 0.08 0.33 0.60
Debt-to-Equity Ratio
 0.13 0.17 0.13 0.82 -3.15
Debt-to-Capital Ratio
 0.11 0.15 0.11 0.45 1.47
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 1.61
Financial Leverage Ratio
 1.55 1.71 1.70 2.52 -5.24
Debt Service Coverage Ratio
 17.41 -3.31 4.99 0.51 -4.47
Interest Coverage Ratio
 18.63 -4.62 3.69 3.29 -5.15
Debt to Market Cap
 0.00 0.00 0.00 0.18 0.42
Interest Debt Per Share
 0.13 0.12 0.09 0.46 0.74
Net Debt to EBITDA
 -0.69 2.15 -2.18 0.31 -1.52
Profitability Margins
Gross Profit Margin
69.20%47.85%54.46%64.91%58.87%
EBIT Margin
30.66%-8.37%9.77%17.93%-24.91%
EBITDA Margin
32.60%-5.60%12.21%19.75%-22.63%
Operating Profit Margin
28.89%-10.43%7.34%15.97%-27.32%
Pretax Profit Margin
29.10%-10.63%7.78%13.08%-30.22%
Net Profit Margin
23.50%-12.52%5.49%12.69%-31.33%
Continuous Operations Profit Margin
23.50%-12.52%5.49%12.69%-31.33%
Net Income Per EBT
80.74%117.76%70.58%97.03%103.68%
EBT Per EBIT
100.74%101.96%106.05%81.89%110.63%
Return on Assets (ROA)
17.17%-8.02%3.99%9.84%-26.76%
Return on Equity (ROE)
31.61%-13.69%6.79%24.76%140.29%
Return on Capital Employed (ROCE)
29.50%-9.85%8.20%26.89%-55.72%
Return on Invested Capital (ROIC)
23.33%-9.61%5.61%16.38%-53.17%
Return on Tangible Assets
17.17%-8.02%3.99%9.84%-26.76%
Earnings Yield
8.94%-4.67%2.15%6.92%-22.48%
Efficiency Ratios
Receivables Turnover
 4.89 5.97 18.36 12.42 10.39
Payables Turnover
 3.82 5.23 5.36 5.32 3.34
Inventory Turnover
 0.77 1.07 1.14 1.21 1.17
Fixed Asset Turnover
 5.91 4.19 5.33 6.02 4.94
Asset Turnover
 0.73 0.64 0.73 0.78 0.85
Working Capital Turnover Ratio
 1.35 1.41 1.81 3.55 2.33
Cash Conversion Cycle
 453.74 332.79 270.68 263.24 238.99
Days of Sales Outstanding
 74.72 61.17 19.88 29.38 35.14
Days of Inventory Outstanding
 474.65 341.39 318.83 302.47 313.06
Days of Payables Outstanding
 95.63 69.78 68.04 68.61 109.21
Operating Cycle
 549.37 402.57 338.72 331.85 348.20
Cash Flow Ratios
Operating Cash Flow Per Share
 0.12 -0.15 0.12 -0.02 -0.52
Free Cash Flow Per Share
 0.10 -0.17 0.10 -0.04 -0.53
CapEx Per Share
 0.03 0.02 0.02 0.02 0.01
Free Cash Flow to Operating Cash Flow
 0.77 1.14 0.85 1.87 1.03
Dividend Paid and CapEx Coverage Ratio
 4.40 -7.32 6.77 -1.15 -39.81
Capital Expenditure Coverage Ratio
 4.40 -7.32 6.77 -1.15 -39.81
Operating Cash Flow Coverage Ratio
 1.08 -1.44 1.57 -0.05 -0.75
Operating Cash Flow to Sales Ratio
 0.12 -0.23 0.16 -0.02 -0.52
Free Cash Flow Yield
3.59%-9.64%5.42%-2.05%-38.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 11.00 -21.40 46.53 14.46 -4.45
Price-to-Sales (P/S) Ratio
 2.65 2.68 2.55 1.83 1.39
Price-to-Book (P/B) Ratio
 2.97 2.93 3.16 3.58 -6.24
Price-to-Free Cash Flow (P/FCF) Ratio
 27.84 -10.37 18.45 -48.71 -2.59
Price-to-Operating Cash Flow Ratio
 21.36 -11.79 15.72 -91.18 -2.66
Price-to-Earnings Growth (PEG) Ratio
 -0.02 0.07 -0.70 -0.10 0.09
Price-to-Fair Value
 2.97 2.93 3.16 3.58 -6.24
Enterprise Value Multiple
 7.43 -45.74 18.73 9.60 -7.68
Enterprise Value
 195.30M 135.02M 122.12M 124.23M 82.77M
EV to EBITDA
 7.43 -45.74 18.73 9.60 -7.68
EV to Sales
 2.42 2.56 2.29 1.90 1.74
EV to Free Cash Flow
 25.47 -9.91 16.52 -50.36 -3.23
EV to Operating Cash Flow
 19.68 -11.26 14.08 -94.26 -3.31
Tangible Book Value Per Share
 0.89 0.61 0.60 0.50 -0.22
Shareholders’ Equity Per Share
 0.89 0.61 0.60 0.50 -0.22
Tax and Other Ratios
Effective Tax Rate
 0.19 -0.18 0.29 0.03 -0.04
Revenue Per Share
 1.01 0.67 0.74 0.97 0.98
Net Income Per Share
 0.24 -0.08 0.04 0.12 -0.31
Tax Burden
 0.81 1.18 0.71 0.97 1.04
Interest Burden
 0.95 1.27 0.80 0.73 1.21
Research & Development to Revenue
 0.25 0.36 0.24 0.26 0.62
SG&A to Revenue
 0.16 0.22 0.23 0.00 -0.29
Stock-Based Compensation to Revenue
 0.03 0.04 0.06 0.05 0.04
Income Quality
 0.52 1.82 2.96 -0.16 1.67
Currency in USD